Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease

NCT03396120 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03396120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease
Lead sponsor
Assiut University
Phase
Observational
Overall status
Completed
Start date
February 2, 2017
Completion date
December 31, 2017
Enrollment
95 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, pulmonary hypertension